Literature DB >> 26693822

Preeclampsia and Pregnancy-Related Hypertensive Disorders.

S Ananth Karumanchi1, Joey P Granger2.   

Abstract

Our understanding of hypertension during pregnancy and, in particular, preeclampsia has changed dramatically over the last decade. During the last year (2014–2015), several articles published in Hypertension have provided important insights into the pathogenesis of preeclampsia and its related complications.1–38 In addition, Hypertension also published some key research communications that translated important basic science observations into the clinic. Some of these articles are briefly discussed, highlighting their significance to our understanding of the mechanism of the disease, to predict the disease and to treat or prevent hypertension during pregnancy and other preeclampsia-related complications.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26693822      PMCID: PMC4755281          DOI: 10.1161/HYPERTENSIONAHA.115.05024

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  53 in total

1.  17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model.

Authors:  Lorena M Amaral; Denise C Cornelius; Ashlyn Harmon; Janae Moseley; James N Martin; Babbette LaMarca
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Elevation of urinary adipsin in preeclampsia: correlation with urine protein concentration and the potential use for a rapid diagnostic test.

Authors:  Tao Wang; Rong Zhou; Linbo Gao; Yanyun Wang; Changping Song; Yunhui Gong; Jin Jia; Wei Xiong; Li Dai; Lin Zhang; Huaizhong Hu
Journal:  Hypertension       Date:  2014-06-23       Impact factor: 10.190

3.  MicroRNA-210 contributes to preeclampsia by downregulating potassium channel modulatory factor 1.

Authors:  Rongcan Luo; Xuan Shao; Peng Xu; Yanlei Liu; Yongqing Wang; Yangyu Zhao; Ming Liu; Lei Ji; Yu-Xia Li; Cheng Chang; Jie Qiao; Chun Peng; Yan-Ling Wang
Journal:  Hypertension       Date:  2014-06-30       Impact factor: 10.190

Review 4.  Challenges of studying drugs in pregnancy for off-label indications: pravastatin for preeclampsia prevention.

Authors:  Kirsten Lawrence Cleary; Kelly Roney; Maged Costantine
Journal:  Semin Perinatol       Date:  2014-10-12       Impact factor: 3.300

5.  CD4+ T cells are important mediators of oxidative stress that cause hypertension in response to placental ischemia.

Authors:  Kedra Wallace; Denise C Cornelius; Jeremy Scott; Judith Heath; Janae Moseley; Krystal Chatman; Babbette LaMarca
Journal:  Hypertension       Date:  2014-08-04       Impact factor: 10.190

6.  Bioinformatics approach reveals evidence for impaired endometrial maturation before and during early pregnancy in women who developed preeclampsia.

Authors:  Maria B Rabaglino; Emiel D Post Uiterweer; Arun Jeyabalan; William A Hogge; Kirk P Conrad
Journal:  Hypertension       Date:  2014-11-24       Impact factor: 10.190

7.  Vasopressin in preeclampsia: a novel very early human pregnancy biomarker and clinically relevant mouse model.

Authors:  Mark K Santillan; Donna A Santillan; Sabrina M Scroggins; James Y Min; Jeremy A Sandgren; Nicole A Pearson; Kimberly K Leslie; Stephen K Hunter; Gideon K D Zamba; Katherine N Gibson-Corley; Justin L Grobe
Journal:  Hypertension       Date:  2014-07-07       Impact factor: 10.190

8.  Increased levels of copeptin before clinical diagnosis of preeclampsia.

Authors:  Edwina H Yeung; Aiyi Liu; James L Mills; Cuilin Zhang; Tuija Männistö; Zhaohui Lu; Michael Y Tsai; Pauline Mendola
Journal:  Hypertension       Date:  2014-09-15       Impact factor: 10.190

9.  Copeptin: a new biomarker that is specific for preeclampsia?

Authors:  Denise C Cornelius
Journal:  Hypertension       Date:  2014-09-15       Impact factor: 10.190

10.  Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the Screening for Pregnancy Endpoints (SCOPE) international cohort study.

Authors:  Louise C Kenny; Michael A Black; Lucilla Poston; Rennae Taylor; Jenny E Myers; Philip N Baker; Lesley M McCowan; Nigel A B Simpson; Gus A Dekker; Claire T Roberts; Kelline Rodems; Brian Noland; Michael Raymundo; James J Walker; Robyn A North
Journal:  Hypertension       Date:  2014-09       Impact factor: 10.190

View more
  31 in total

1.  Roles of aryl hydrocarbon receptor in endothelial angiogenic responses†.

Authors:  Yan Li; Chi Zhou; Wei Lei; Kai Wang; Jing Zheng
Journal:  Biol Reprod       Date:  2020-10-29       Impact factor: 4.285

2.  Autonomic Dysfunction in Preeclampsia: A Systematic Review.

Authors:  Dalia Yousif; Ioannis Bellos; Ana Isabel Penzlin; Mido Max Hijazi; Ben Min-Woo Illigens; Alexandra Pinter; Timo Siepmann
Journal:  Front Neurol       Date:  2019-08-06       Impact factor: 4.003

3.  A novel rodent model of pregnancy complications associated with genetically determined angiotensin-converting enzyme (ACE) activity.

Authors:  Eugenia Mata-Greenwood; Arlin B Blood; LeeAnna D Sands; Shannon L Bragg; Daliao Xiao; Lubo Zhang
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-01-23       Impact factor: 4.310

Review 4.  Pregnancy-related acute kidney injury in high income countries: still a critical issue.

Authors:  Fadi Fakhouri; Clément Deltombe
Journal:  J Nephrol       Date:  2017-09-27       Impact factor: 3.902

5.  Toxicological Effects of BPDE on Dysfunctions of Female Trophoblast Cells.

Authors:  Rong Wang; Xinying Huang; Chenglong Ma; Huidong Zhang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Protein Phosphatase 2A Activation Via ApoER2 in Trophoblasts Drives Preeclampsia in a Mouse Model of the Antiphospholipid Syndrome.

Authors:  Haiyan Chu; Anastasia Sacharidou; An Nguyen; Chun Li; Ken L Chambliss; Jane E Salmon; Yu-Min Shen; Julie Lo; Gustavo W Leone; Joachim Herz; David Y Hui; Denise K Marciano; Vikki M Abrahams; Bryony V Natale; Alina P Montalbano; Xue Xiao; Lin Xu; David R Natale; Philip W Shaul; Chieko Mineo
Journal:  Circ Res       Date:  2021-08-18       Impact factor: 23.213

7.  Nested case-control study reveals increased levels of urinary proteins from human kidney toxicity panels in women predicted to develop preeclampsia.

Authors:  Yamile Lopez-Hernandez; Jorge Alejandro Saldivar-Nava; Idalia Garza-Veloz; Ivan Delgado-Enciso; Laura Elia Martinez-de-Villarreal; Patricia Yahuaca-Mendoza; Iram Pablo Rodriguez-Sanchez; Laura Lopez-Gilibets; Jorge Issac Galvan-Tejada; Carlos Eric Galvan-Tejada; Jose Maria Celaya-Padilla; Margarita L Martinez-Fierro
Journal:  Int Urol Nephrol       Date:  2016-08-29       Impact factor: 2.370

8.  Sympathetic nervous system control of vascular function and blood pressure during pregnancy and preeclampsia.

Authors:  Frank T Spradley
Journal:  J Hypertens       Date:  2019-03       Impact factor: 4.844

9.  Should a history of assisted reproductive technology be another consideration when assessing cardiovascular risk?

Authors:  Karen M Goldstein; Lisa S Callegari
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-11-07       Impact factor: 3.738

10.  The role of tumor necrosis factor in triggering activation of natural killer cell, multi-organ mitochondrial dysfunction and hypertension during pregnancy.

Authors:  Aswathi Jayaram; Evangeline Deer; Lorena M Amaral; Nathan Campbell; Venkata Ramana Vaka; Mark Cunningham; Tarek Ibrahim; Denise C Cornelius; Babbette B LaMarca
Journal:  Pregnancy Hypertens       Date:  2021-02-16       Impact factor: 2.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.